Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Neuronetics, Inc. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
STIM
Nasdaq
3840
neurostar.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Neuronetics, Inc.
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Feb 7th, 2025 9:30 pm
Neuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common Stock
- Feb 7th, 2025 12:54 pm
Neuronetics Announces Launch of Underwritten Public Offering of Common Stock
- Feb 6th, 2025 9:23 pm
Why Neuronetics Inc (STIM) Is Skyrocketing So Far In 2025
- Feb 4th, 2025 12:27 am
NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression
- Jan 29th, 2025 1:31 pm
Neuronetics (NASDAQ:STIM) shareholders are up 34% this past week, but still in the red over the last five years
- Jan 29th, 2025 11:03 am
Neuronetics Provides Business Update and Issues 2025 Guidance
- Jan 13th, 2025 1:00 pm
Neuronetics and Greenbrook TMS Announce Closing of Transaction
- Dec 10th, 2024 3:00 pm
Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference
- Nov 20th, 2024 1:30 pm
Neuronetics Third Quarter 2024 Earnings: Misses Expectations
- Nov 18th, 2024 12:30 pm
Need To Know: The Consensus Just Cut Its Neuronetics, Inc. (NASDAQ:STIM) Estimates For 2025
- Nov 17th, 2024 12:23 pm
Neuronetics, Inc. (NASDAQ:STIM) Analysts Are Cutting Their Estimates: Here's What You Need To Know
- Nov 15th, 2024 10:44 am
Neuronetics Inc (STIM) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Rising Expenses ...
- Nov 13th, 2024 7:10 am
CORRECTION—Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results
- Nov 12th, 2024 11:45 pm
Neuronetics (STIM) Reports Q3 Loss, Lags Revenue Estimates
- Nov 12th, 2024 1:20 pm
Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results
- Nov 12th, 2024 12:10 pm
Rave Restaurant Group And 2 Other Promising US Penny Stocks
- Nov 5th, 2024 5:08 pm
Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call
- Oct 29th, 2024 8:30 pm
NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression
- Oct 14th, 2024 12:31 pm
Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings
- Oct 4th, 2024 12:33 pm
Scroll